Risk for dementia found to be similar with SGLT2 inhibitors, dulaglutide in type 2 diabetes
For older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study ...
Aug 27, 2024
0
0